Logo image of FBLG

FIBROBIOLOGICS INC (FBLG) Stock News

NASDAQ:FBLG - Nasdaq - US31573L1052 - Common Stock - Currency: USD

0.75  -0.02 (-2.96%)

After market: 0.749 0 (-0.13%)

FBLG Latest News, Press Relases and Analysis

News Image
13 days ago - Fibrobiologics, Inc.

FibroBiologics Presents at the Society for Investigative Dermatology Annual Meeting

HOUSTON, May 16, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 240+...

News Image
15 days ago - Fibrobiologics, Inc.

FibroBiologics Reports First Quarter 2025 Financial Results and Provides Corporate Update

Preparations for Phase 1/2 clinical trial in Australia utilizing fibroblast-based spheroids product candidate, CYWC628, to treat diabetic foot ulcers are...

News Image
15 days ago - Fibrobiologics, Inc.

FibroBiologics Reports First Quarter 2025 Financial Results and Provides Corporate Update

Preparations for Phase 1/2 clinical trial in Australia utilizing fibroblast-based spheroids product candidate, CYWC628, to treat diabetic foot ulcers are proceeding with plans to initiate in the third quarter of 2025

News Image
5 months ago - Fibrobiologics, Inc.

FibroBiologics Announces $25 Million Financing

HOUSTON, Dec. 23, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (

News Image
a month ago - Fibrobiologics, Inc.

FibroBiologics Presents at the ThymUS 2025 Meeting

HOUSTON, April 29, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 240+...

News Image
a month ago - Fibrobiologics, Inc.

FibroBiologics Presenting at the ThymUS 2025 Meeting

HOUSTON, April 29, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 240+...

News Image
2 months ago - Fibrobiologics, Inc.

FibroBiologics to Present at The Cell & Gene Meeting on the Mediterranean

HOUSTON, April 11, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (

News Image
2 months ago - Fibrobiologics, Inc.

FibroBiologics Unveils New and Expanded Houston Laboratory Space to Pursue Innovation and Breakthroughs in Fibroblast-Based Therapeutics

Located in Houston, Texas, the new facility allows FibroBiologics to expand its research and development efforts utilizing fibroblast-based technology...

News Image
2 months ago - Fibrobiologics, Inc.

FibroBiologics Unveils New and Expanded Houston Laboratory Space to Pursue Innovation and Breakthroughs in Fibroblast-Based Therapeutics

Located in Houston, Texas, the new facility allows FibroBiologics to expand its research and development efforts utilizing fibroblast-based technology

News Image
2 months ago - Fibrobiologics, Inc.

FibroBiologics gibt wissenschaftlicher Fortschritte bei der Reparatur von Hirngewebe bekannt

HOUSTON, April 03, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (im Folgenden kurz „FibroBiologics“), ein im klinischen Stadium tätiges...

News Image
2 months ago - Fibrobiologics, Inc.

FibroBiologics annonce des progrès scientifiques suite à la confirmation des résultats relatifs à la réparation de tissus cérébraux

HOUSTON, 03 avr. 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq : FBLG), ou « FibroBiologics », une société de biotechnologie au stade clinique...

News Image
2 months ago - Fibrobiologics, Inc.

FibroBiologics Announces Scientific Advancement in Confirmation Results of Brain Tissue Repair

HOUSTON, April 02, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (

News Image
2 months ago - Fibrobiologics, Inc.

FibroBiologics Reports Full Year 2024 Financial Results and Provides Corporate Update

Proprietary master cell bank of fibroblast-based spheroids product candidate, CYWC628, completed in accordance with Good Manufacturing Practices after...

News Image
2 months ago - Fibrobiologics, Inc.

FibroBiologics Announces 2025 Annual Meeting of Stockholders

HOUSTON, March 27, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 160+...

News Image
2 months ago - Fibrobiologics, Inc.

FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting

HOUSTON, March 21, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 160+...

News Image
3 months ago - Virtual Investor Conferences

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

Mentions: CGTX AVCN.CA COCP NGEN.CA ...

News Image
3 months ago - Virtual Investor Conferences

Life Sciences Investor Forum Agenda Announced for March 13th

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

Mentions: CGTX AVCN.CA COCP NGEN.CA ...

News Image
3 months ago - Fibrobiologics, Inc.

フィブロバイオロジックス (FibroBiologics)、線維芽細胞ベースの治療薬を用いたミトコンドリア活性の調節に関する新規アプローチで特許申請

この革新的な手法は、ミトコンドリアの機能異常が原因で起こる慢性疾患の新たな治療法につながる可能性が期待されている。 ヒューストン発 , March 05, 2025 (GLOBE NEWSWIRE) --...

News Image
3 months ago - Fibrobiologics, Inc.

FibroBiologics meldet Patent für neuartigen Ansatz zur Modulation mitochondrialer Aktivität mithilfe von auf Fibroblasten basierten Therapeutika an

Diese innovative Methode hat das Potenzial, neue Behandlungsmöglichkeiten für chronische Erkrankungen zu erschließen, die durch mitochondriale...

News Image
3 months ago - Fibrobiologics, Inc.

FibroBiologics dépose une demande de brevet pour une nouvelle approche visant à moduler l’activité mitochondriale à l’aide de produits thérapeutiques à base de fibroblastes

Cette nouvelle méthode pourrait ouvrir la voie vers de nouvelles options thérapeutiques ciblées sur des maladies chroniques causées par un...

News Image
3 months ago - Fibrobiologics, Inc.

FibroBiologics Files Patent For Novel Approach to Modulate Mitochondrial Activity Using Fibroblast-based Therapeutics

This innovative method has the potential to unlock new treatment options for chronic conditions driven by mitochondrial dysregulation. HOUSTON, March 04,...

News Image
3 months ago - Fibrobiologics, Inc.

FibroBiologics and Charles River Announce Completion and Release of CYWC628 Master Cell Bank for the Manufacturing of Fibroblast Cell-based Wound Healing Therapeutic

Master cell bank to be used in manufacturing of CYWC628 drug product to support upcoming clinical trial for diabetic foot ulcers...

News Image
3 months ago - Fibrobiologics, Inc.

FibroBiologics and Charles River Announce Completion and Release of CYWC628 Master Cell Bank for the Manufacturing of Fibroblast Cell-based Wound Healing Therapeutic

Master cell bank to be used in manufacturing of CYWC628 drug product to support upcoming clinical trial for diabetic foot ulcers

News Image
4 months ago - Fibrobiologics, Inc.

FibroBiologics to Host In-Person Analyst Day to Provide Research & Development Updates

FibroBiologics to also present at the BIO CEO & Investor Conference...

News Image
4 months ago - Fibrobiologics, Inc.

FibroBiologics to Host In-Person Analyst Day to Provide Research & Development Updates

FibroBiologics to also present at the BIO CEO & Investor Conference

News Image
5 months ago - Fibrobiologics, Inc.

FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing

HOUSTON, Dec. 30, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (